What to Expect at the Inaugural Immune Resetting: B-Cell Mediated & Beyond Summit?
Immune resetting is no longer a concept; it’s the next frontier in autoimmune therapy. Advances in B-cell depletion, BCMA-targeted strategies, and combination approaches with T-cell modulation are redefining what durable remission looks like. With cell therapies, T-cell engagers, bispecifics, and precision biologics moving from theory to clinic, the race to deliver curative potential is accelerating. The inaugural Immune Resetting: B-Cell Mediated & Beyond Summit is your chance to be at the center of this transformation, connecting with leading biopharma, academic KOLs, and innovators to shape strategies, build partnerships, and unlock actionable insights. If you want to influence the future of autoimmune care, this is the meeting you can’t afford to miss.
What to Expect?
Join this dynamic, immunology-driven program designed to push the boundaries of autoimmune innovation:
Dive into the Morning Workshop session with Kite Pharma and Ricardo Greishaber-Bouyer to define what true immune resetting means, exploring the depth of B-cell depletion, key biomarkers, and cutting-edge profiling tools shaping next-generation therapies.
Connect and collaborate at our Poster Session, where you can showcase research and discover breakthroughs from discovery through to clinical application.
Go beyond B-cell targeting with Marengo Therapeutics to uncover why disrupting the T/B-cell axis and modulating pathogenic T-cell subsets is critical for durable remission.
Unlock the potential of BCMA with Ouro Medicines, examining strategies to eliminate long-lived plasma cells and weigh the pros and cons of alternative targets.
Join Bristol Myers Squibb and Cullinan Therapeutics for a high-level debate on clinical development challenges, patient selection, and the ‘window of opportunity’ for intervention.
Connect with leading experts and engage in curated networking sessions, interactive roundtables, and collaborative discussions designed to spark partnerships and accelerate breakthroughs in immune resetting.
This is your chance to engage with leading minds, benchmark strategies, and take actionable insights back to your programs, shaping the future of immune resetting therapies.
This is a rapidly evolving space, and the collaboration and information shared from companies was incredibly valuable at the TCEs for Autoimmune Disease Summit. I think we all believe we are competing but also each success will help the whole field out
Chief Medical Officer, Oblenio Bio
I look forward to hearing and seeing the latest development in immune resetting and meeting with a diverse group of researchers in this field
Senior Director, Hinge Bio
Explore the Full Event Guide
- 50+ Industry Attendees
- 18+ World-Class Speakers
- 5+ Modalities Covered
- 6+ Hours of Unrivaled Networking Opportunities
- 2 Deep-Dive Workshops
- The only industry forum dedicated to advancing curative therapies for autoimmune diseases through immune resetting
Attending Companies Include
Explore the Brand-New Agenda
Hear the latest industry breakthroughs in B-cell mechanistic understanding and gain exclusive modality and platform insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself as the go-to service provider of the rapidly progressing ‘Immune Resetting’ landscape to ensure your brand is at the heart of deals in this evolving space.
Join Biopharma Experts
Be part of the most critical conversations shaping the future of autoimmune therapy. Connect with like-minded experts across every stage of drug development, from discovery to clinical application, and dive into focused discussions on redefining immune reset.